The drug candidate was demonstrated to be well-tolerated and the pain and quality of life survey results suggested a potential for rapid improvement of peripheral neuropathy symptoms and post ...

DOI: 10.1126/sciadv.adn8760 Citation: Cancer drug could be used to save the limbs of peripheral artery disease patients, pre-clinical study suggests (2024, October 11) retrieved 2 November 2024 ...

The causal relationship of liver disease to neuropathy has been questioned. This study was designed to evaluate the incidence and character of peripheral neuropathy in patients with liver cirrhosis.

[1],4-8,20] This might be due to differences in patient selection or variation in the criteria used for the definition ... can independently cause peripheral neuropathy. Hence, a cause and effect ...

︎ Diabetic peripheral neuropathy, which affects about 30% of diabetics ... the first line of treatment and includes medications that act on the nervous system to try to reduce pain. These medications ...

Mumbai: Alkem Laboratories Ltd. has entered into a licensing agreement with US-based Sonnet BioTherapeutics Holdings, Inc to develop, manufacture and commercialise the drug candidate “SON-080” for the ...

One benefit of Cymbalta is that it can be taken as one capsule once daily, which makes adherence much easier. This is in contrast to other medications commonly used to treat peripheral neuropathy that ...

aDivision of Infectious Diseases, Emory University Medical School, Atlanta, GA, USA bDivision of Neurology, Emory University Medical School, Atlanta, GA, USA ...

Researchers at the Heart Research Institute (HRI) have made a new discovery, finding an existing drug used to kill tumor ...

Alkem Laboratories partners with Sonnet BioTherapeutics to develop and commercialize SON-080, a potential treatment for diabetic peripheral neuropathy in India. The drug has shown promising nerve ...